MADIT-II: Risk of Long-Term Mortality Reduced with ICDs

Cardiology Today -- Results of the MADIT-II trial showed that patients who received an implantable cardioverter defibrillator had a 45% mortality probability compared with a 61% risk among patients who did not receive the device.